RE: SynaIrgen's SNG001 v's Prepbiopharma's PrEP00124 Jul 2020 08:43
Barwick everyone's allowed an opinion on their investments. Or do you only like ramping here? We have heard umpteen podcasts, webinars for months just repeating the same rehearsed speech and had no names or numbers RNSd. For a company that is testing as much as they said they would be I would expect an RNS giving an income amount from antibody testing the previous month (we signed the Quotient deal on the 11th May, How much has been made from that since it started?). Nothing to do with NDAs and secret signed contracts with pharmas. Although the other top 3 must be overdue now or fell through imo. Just getting frustrated seeing most other pharmas fly recently and this one stagnant.